Twitxy Saved

Crispin Hiley

@crispinhiley

Lung and Metastatic Cancer Specialist. Associate Professor. Consultant Oncologist. @uclh @uclcancer @CRUKLungCentre @genesiscare
London, England crispinhiley.com Joined March 2010
1.4K Following 1.6K Followers 2.6K Posts

Latest posts 5

Pinned post

Crispin Hiley @crispinhiley
With all the new data regarding first line treatments for patients with metastatic EGFR mutation positive lung cancer at #ASCO2024 this is an important paper regarding the role of TP53 co-mutations and mixed/discordant responses to treatment with EGFR TKI. So pleased it’s out! 1/2
Charles Swanton @CharlesSwanton Jun 13, 2024
Why do some patients benefit less than others from precision cancer medicine? We are excited to share our paper "Mixed responses to targeted therapy driven by chromosomal instability through p53 dysfunction and genome doubling” out in @NatureComms. nature.com/articles/s4146… 🧵
View quoted post on X
4 replies 1 reposts 24 likes 6.3K views View on X
Crispin Hiley @crispinhiley
Very kind to have been asked by my dear friend Roberto Salgado to contribute to this Lancet Oncology Review on TILs and breast radiotherapy.

TILs are clearly prognostic in breast cancer. Whether they genuinely predict radiotherapy benefit is much less certain.

For me, the interesting question is not simply who might receive less RT, but whether immune biology can eventually help us refine dose, volume and treatment intensity in both directions.

The challenge is proving it. Breast radiotherapy trials are large and take years to mature, so careful translational work using existing randomised datasets will be important.

A really enjoyable collaboration.

thelancet.com/journals/lanon…
Crispin Hiley @crispinhiley
This good news. Look forward to seeing the data - ?ESMO26
Masahiro TORASAWA, MD. PhD. Verified account @M_Torasawa Aug 17
🚨 Phase 3 SAFFRON met its primary endpoint

Savolitinib + osimertinib significantly improved PFS and OS vs. platinum-based chemo in EGFRm NSCLC with MET overexpression/amplification after progression on osimertinib.

🔥 First global P3 trial to show both PFS and OS benefit in this setting!

🔗 hutch-med.com/saffron-global…
View quoted post on X
Crispin Hiley @crispinhiley
Fascinating and simple study. Sometime I think patient perception of protons is related to the absence of the word ‘radiation’ in ‘proton therapy’
Can a single word influence cancer treatment preferences?

In our randomized experiment, calling the same treatment “radiotherapy” rather than “radiation therapy” increased preference for radiation treatment by 8.3 percentage points.

Just published in @IJROBP: redjournal.org/article/S0360-…

With @KatLudwikowska & @JustynaKlejdysz
View quoted post on X
0 replies 2 reposts 6 likes 1.3K views View on X
Crispin Hiley @crispinhiley
Delighted to see our perspective on adapting #ProjectOptimus for radiotherapy–drug combinations published in @IJROBP .

If you work in radiation oncology, I’d really appreciate you taking a few minutes to read it. I know everyone’s time is valuable, but I hope it starts a conversation about how we design early-phase RT–drug trials.

Great to work with such a fantastic group of colleagues.

sciencedirect.com/science/articl…